KENT BRAEUTIGAM: Open Payments
NPI 1063437861 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 120 payments from 24 companies in 2025. Trend: 2023 $2,516 · 2024 $1,811 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $295 |
| AstraZeneca Pharmaceuticals LP | 9 | $286 |
| Lilly USA, LLC | 14 | $228 |
| Novo Nordisk Inc | 12 | $216 |
| Vanda Pharmaceuticals Inc. | 12 | $194 |
| Amgen Inc. | 14 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| SANOFI-AVENTIS U.S. LLC | 4 | $102 |
| Biogen, Inc. | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
Products named: BREZTRI, VRAYLAR, FANAPT, REXULTI, MOUNJARO, Wegovy, CAPLYTA, TZIELD.
Industry payments across FL — which companies pay providers there.
